Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Short Communication
Authors: Swerdlow, Neal R.a; * | Kotz, Juliana E.a | Joshi, Yash B.a; d | Talledo, Joa | Sprock, Joycea; d | Molina, Juan L.a; d | Huisa, Brankob | Huege, Steven F.a | Romero, Jairo Albertoc | Walsh, Michael J.a | Delano-Wood, Lisaa | Light, Gregory A.a; d
Affiliations: [a] Department of Psychiatry, School of Medicine, University of California, San Diego, La Jolla, CA, USA | [b] Department of Neurosciences, School of Medicine, University of California, San Diego, La Jolla, CA, USA | [c] Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA, USA | [d] VISN-22 Mental Illness, Research, Education and Clinical Center (MIRECC), VA San Diego Healthcare System, San Diego, CA, USA
Correspondence: [*] Correspondence to: Neal R. Swerdlow, MD, PhD, Distinguished Professor, Department of Psychiatry 0804, UCSD School of Medicine, 9500 Gilman Dr., La Jolla, CA 92093-0804, USA. E-mail: nswerdlow@ucsd.edu.
Abstract: Memantine’s benefits in Alzheimer’s disease (AD) are modest and heterogeneous. We tested the feasibility of using sensitivity to acute memantine challenge to predict an individual’s clinical response. Eight participants completed a double-blind challenge study of memantine (placebo versus 20 mg) effects on autonomic, subjective, cognitive, and neurophysiological measures, followed by a 24-week unblinded active-dose therapeutic trial (10 mg bid). Study participation was well tolerated. Subgroups based on memantine sensitivity on specific laboratory measures differed in their clinical response to memantine, some by large effect sizes. It appears feasible to use biomarkers to predict clinical sensitivity to memantine.
Keywords: Alzheimer’s disease, event-related potentials, memantine, neurocognition, prepulse inhibition
DOI: 10.3233/JAD-215029
Journal: Journal of Alzheimer's Disease, vol. 84, no. 4, pp. 1431-1438, 2021
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl